| Synonyms: | |
| Status: | Approved (2023) |
| Entry Type: | Oligonucleotide |
| Molecule Category: | UNKNOWN |
| UNII: | 0GRZ0F5XJ6 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTISENSE INHIBITOR | Transthyretin mRNA antisense inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Amyloid Neuropathies, Familial | 3 | D028227 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4594334 |
| FDA SRS | 0GRZ0F5XJ6 |
CONTENTS